{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T21:01:34Z","timestamp":1771102894475,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0801-y","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T07:34:44Z","timestamp":1530603284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Amyloidosis due to TTR mutations in Mexico with 4 distincts genotypes in the index cases"],"prefix":"10.1186","volume":"13","author":[{"given":"Alejandra","family":"Gonz\u00e1lez-Duarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla","family":"C\u00e1rdenas-Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Enrico","family":"Ba\u00f1uelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Fueyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjam\u00edn","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Cant\u00fa-Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"issue":"2","key":"801_CR1","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","volume":"10","author":"V Plant\u00e9-Bordeneuve","year":"2011","unstructured":"Plant\u00e9-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol. 2011;10(2):1086\u201397.","journal-title":"Lancet Neurol"},{"key":"801_CR2","doi-asserted-by":"crossref","unstructured":"Sousa A, Coelho T, Barros J et al. Genetic epidemiology of familial amylodotic polyneuropathy (FAP) type I in Povoa do Varzim and Vila do Conde (North of Portugal). Am J Med Genet 1995;60:512-521.","DOI":"10.1002\/ajmg.1320600606"},{"key":"801_CR3","unstructured":"Coelho T, Ericzon B, Roy Grogan D. A Physician\u2019s guide to Transthyretin Amyloidosis. Amyloidosis Fundation. 2010."},{"issue":"1","key":"801_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/13506120701815373","volume":"15","author":"C Rapezzi","year":"2008","unstructured":"Rapezzi C, Riva L, Quarta C, et al. Gender-related risk of myocardial involvement in systemic amyloidosis. Amyloid. 2008;15(1):40\u20138.","journal-title":"Amyloid"},{"issue":"2","key":"801_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/13506120701259580","volume":"14","author":"M Munar-Qu\u00e9s","year":"2007","unstructured":"Munar-Qu\u00e9s M, MasJuan J, Coelho T, et al. Familial amyloid polyneuropathy associated with TTRSer50Arg mutation in two Iberian families presenting a novel single base change in the mutant gene. Amyloid. 2007;14(2):147\u201352.","journal-title":"Amyloid"},{"issue":"7","key":"801_CR6","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1212\/WNL.58.7.1001","volume":"58","author":"S Ikeda","year":"2002","unstructured":"Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy: clinical and genetic heterogeneity. Neurology. 2002;58(7):1001\u20137.","journal-title":"Neurology"},{"key":"801_CR7","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/archneur.59.11.1771","volume":"59","author":"H Koike","year":"2002","unstructured":"Koike H, Misu K, Ikeda S, et al. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form. Arch Neurol. 2002;59:1771\u20136.","journal-title":"Arch Neurol"},{"issue":"4","key":"801_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/13506129.2012.712925","volume":"19","author":"A Gonzalez-Duarte","year":"2012","unstructured":"Gonzalez-Duarte A, Soto KC, Mart\u00ednez-Ba\u00f1os D, et al. Familial amyloidosis with polyneuropathy associated with TTR Ser50Arg mutation. Amyloid. 2012;19(4):171\u20136.","journal-title":"Amyloid"},{"issue":"4","key":"801_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3109\/13506129.2013.827110","volume":"20","author":"A Gonzalez-Duarte","year":"2013","unstructured":"Gonzalez-Duarte A, Lem-Carrillo M, C\u00e1rdenas Soto K. Description of transthyretin S50A, S52P and G47A mutations in familial amyloidosis polyneuropathy. Amyloid. 2013;20(4):221\u20135.","journal-title":"Amyloid"},{"issue":"Suppl 1","key":"801_CR10","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/WCO.0000000000000289","volume":"29","author":"D Adams","year":"2016","unstructured":"Adams D, Suhr B, Hund E, et al. First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Curr Opin Neurol. 2016;29(Suppl 1):S14\u201326.","journal-title":"Curr Opin Neurol"},{"key":"801_CR11","first-page":"88","volume-title":"Amyloid and amyloidosis","author":"P Coutinho","year":"1980","unstructured":"Coutinho P, Martins da Silva A, Lopes Lima J, Resende Barbosa A. Forty years of experience with type I amyloid neuropathy. Review of 483 cases. In: Glenner G, Costa P, de Freitas A, editors. Amyloid and amyloidosis. Amsterdam: Execerpta Medica; 1980. p. 88\u201398."},{"key":"801_CR12","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1111\/j.1600-6143.2007.01969.x","volume":"7","author":"S Yamamoto","year":"2007","unstructured":"Yamamoto S, Wilczek H, Nowak G, Larsson M, Oksanen A, Iwata T, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant. 2007;7:2597\u2013604.","journal-title":"Am J Transplant"},{"key":"801_CR13","unstructured":"Consejo Nacional de Poblaci\u00f3n (CONAPO). Proyecciones de la Poblaci\u00f3n 2010-2050. \n                    https:\/\/www.gob.mx\/conapo\/acciones-y-programas\/proyecciones-de-la-poblacion-2010-2050\n                    \n                  ."},{"issue":"1","key":"801_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1750-1172-9-29","volume":"9","author":"J Buades","year":"2014","unstructured":"Buades J, Ripoll T, Us\u00f3n M, et al. Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: son Ll\u00e0tzer hospital descriptive study. Orphanet J Rare Dis. 2014;9(1):29.","journal-title":"Orphanet J Rare Dis"},{"key":"801_CR15","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.3233\/JND-150091","volume":"2","author":"A Mazzeo","year":"2015","unstructured":"Mazzeo A, Russo M, Di Bella G, et al. Transthyretin-related familial amyloid polyneuropathy (TTR-FAP): a single-center experience in Sicily, an Italian endemic area. J Neuromuscul Dis. 2015;2:S39\u201348.","journal-title":"J Neuromuscul Dis"},{"issue":"Suppl 1","key":"801_CR16","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/WCO.0000000000000288","volume":"29","author":"Y Parman","year":"2016","unstructured":"Parman Y, Adams D, Obici L, Gal\u00e1n L, et al. Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol. 2016;29(Suppl 1):S3\u2013S13.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"801_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/13506120802676948","volume":"16","author":"E Dardiotis","year":"2009","unstructured":"Dardiotis E, Koutsou P, Papanicolaou EZ, et al. Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus. Amyloid. 2009;16(1):32\u20137.","journal-title":"Amyloid"},{"issue":"1-2","key":"801_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jns.2008.02.019","volume":"270","author":"Y Kato-Motozaki","year":"2008","unstructured":"Kato-Motozaki Y, Ono K, Shima K, Morinaga A, Machiya T, et al. Epidemiology of familial amyloid polyneuropathy in Japan: identification of a novel endemic focus. J Neurol Sci. 2008;270(1-2):133\u201340.","journal-title":"J Neurol Sci"},{"issue":"1.2","key":"801_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0022-510X(92)90132-5","volume":"112","author":"N Takahashi","year":"1992","unstructured":"Takahashi N, Ueno S, Uemichi T, Fujimura H, Yorifuji S, Tarui S. Amyloid polyneuropathy with transthyretin Arg50 in a Japanese case from Osaka. J Neurol Sci. 1992;112(1.2):58\u201364.","journal-title":"J Neurol Sci"},{"key":"801_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/humu.1380040110","volume":"4","author":"A Ferlini","year":"1994","unstructured":"Ferlini A, Patrosso MC, Repetto M, Frattini A, Villa A, Fini S, Vezzoni P, Forabosco A. A new mutation (TTR ala-47) in the transthyretin gene associated with hereditary amyloidosis. Hum Mutat. 1994;4:61\u20134.","journal-title":"Hum Mutat"},{"key":"801_CR21","doi-asserted-by":"crossref","unstructured":"Montagna P, Marchello L, Plasmati R, Ferlini A, Patrosso MC, Salvi F. Electromyographic findings in transthyretin (TTR)-related familial amyoloid polyneuropathy (FAP). Electroencephalogr Clin Neurophysiol 1996;101(5):423-430.","DOI":"10.1016\/0924-980X(96)95662-3"},{"issue":"2","key":"801_CR22","first-page":"48","volume":"77","author":"LA Franco D\u00edaz","year":"2003","unstructured":"Franco D\u00edaz LA, Rodriguez Reyes AA, G\u00f3mez Leal A. Amiloidosis Familiar Cong\u00e9nita. Rev Mex Oftalm. 2003;77(2):48\u201351.","journal-title":"Rev Mex Oftalm"},{"key":"801_CR23","doi-asserted-by":"crossref","unstructured":"Chakraborty, Ranajit. Human Population Genetics: Drift and Migration. Encyclopedia of Life Sciences, John Wiley & Sons Ltd. 2008:1-5.","DOI":"10.1002\/9780470015902.a0001786.pub2"},{"key":"801_CR24","doi-asserted-by":"crossref","unstructured":"Zlotogora J. Genetic Disease: Prevalence. Encyclopedia of Life Sciences, John Wiley & Sons Ltd. 2005:1-4.","DOI":"10.1038\/npg.els.0006004"},{"key":"801_CR25","doi-asserted-by":"crossref","unstructured":"Whitlock M, Phillips P. Drift: Introduction. Encyclopedia of Life Sciences, John Wiley & Sons Ltd. 2001:1-4.","DOI":"10.1038\/npg.els.0001698"},{"key":"801_CR26","unstructured":"Secretar\u00eda de Gobernaci\u00f3n, Centro Nacional de Desarrollo Municipal, Sistema Nacional de Informaci\u00f3n Municipal, agosto de 2001, M\u00e9xico, D.F."},{"issue":"2","key":"801_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cell.2010.03.032","volume":"141","author":"J McClellan","year":"2010","unstructured":"McClellan J, King MC. Genetic heterogeneity in human disease. Cell. 2010;141(2):210\u20132017.","journal-title":"Cell"},{"key":"801_CR28","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s004390050991","volume":"104","author":"M Soares","year":"1999","unstructured":"Soares M, BUxbam J, Sirugo G, Coelho T, Sousa A, Kastner D, Saraiva. Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions. Hum Genet. 1999;104:480\u20135.","journal-title":"Hum Genet"},{"key":"801_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/jmg.35.1.23","volume":"35","author":"K Yamamoto","year":"1998","unstructured":"Yamamoto K, Ikeda S, Hanuy H. A pedigree analysis with minimized ascertainment bias shows anticipation in Met30- transthyretin related familial amyloid polyneuropathy. J Med Genet. 1998;35:23\u201330.","journal-title":"J Med Genet"},{"key":"801_CR30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/jmg.30.5.388","volume":"30","author":"U Drugge","year":"1993","unstructured":"Drugge U, Andersson R, et al. Familial amyloidotic polyneuropathy in Sweden: a pedigree analyisis. J Med Genet. 1993;30:388\u201392.","journal-title":"J Med Genet"},{"key":"801_CR31","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2183\/pjab.86.694","volume":"86","author":"S Araki","year":"2010","unstructured":"Araki S, Ando Y. Transthyretin-related familial amyloidotic polyneuropathy progress in Kumamoto, Japan (1967-2010). Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:694\u20137.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"2","key":"801_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1478-3231.2005.01208.x","volume":"26","author":"P Rimessi","year":"2006","unstructured":"Rimessi P, Spitali P, Ando Y, Mazzaferro V, Pastorelli F, Tassinari CA, Calzolari E, Salvi F, Ferlini A. Transthyretin RNA profiling in livers from transplanted patients affected by familial amyloidotic polyneuropathy, and identification of a dual transcription start point. Liver Int. 2006;26(2):211\u201320.","journal-title":"Liver Int"},{"key":"801_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-8-31","volume":"8","author":"Y Ando","year":"2013","unstructured":"Ando Y, Coelho T, Berk J, et al. Guideline of trasthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013;8:31.","journal-title":"Orphanet J Rare Dis"},{"issue":"1-2","key":"801_CR34","first-page":"16","volume":"40","author":"A Castillo Ch\u00e1vez","year":"1975","unstructured":"Castillo Ch\u00e1vez A, Haua Kuri J, Cervantes LF. Retrospective analysis of 44 cases of amyloidosis. Prensa Med Mex. 1975;40(1-2):16\u201320.","journal-title":"Prensa Med Mex"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0801-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0801-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0801-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T19:24:09Z","timestamp":1562095449000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0801-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0801-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"13 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol of the study was approved by the Ethics Committee (IRB) of the Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n (NER 332). All patients signed an informed consent before testing.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"107"}}